Compare EVAX & UGRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVAX | UGRO |
|---|---|---|
| Founded | 2008 | 2014 |
| Country | Denmark | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.7M | 3.0M |
| IPO Year | 2021 | N/A |
| Metric | EVAX | UGRO |
|---|---|---|
| Price | $4.85 | $0.35 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $12.33 | $3.00 |
| AVG Volume (30 Days) | 109.7K | ★ 14.0M |
| Earning Date | 11-06-2025 | 03-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $7,650,000.00 | ★ $59,985,138.00 |
| Revenue This Year | $128.77 | N/A |
| Revenue Next Year | N/A | $28.40 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 132.17 | N/A |
| 52 Week Low | $1.20 | $0.21 |
| 52 Week High | $12.15 | $1.19 |
| Indicator | EVAX | UGRO |
|---|---|---|
| Relative Strength Index (RSI) | 42.56 | 59.99 |
| Support Level | $4.60 | $0.32 |
| Resistance Level | $6.70 | $0.49 |
| Average True Range (ATR) | 0.53 | 0.07 |
| MACD | -0.13 | 0.01 |
| Stochastic Oscillator | 13.79 | 48.74 |
Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.
Urban-gro Inc is an integrated professional services and construction design-build firm. Its business focuses predominantly on providing fee-based knowledge-based services as well as the value-added reselling of equipment. The company offers value-added architectural, engineering, systems procurement and integration, and construction design-build solutions to customers operating in the controlled environment agriculture (CEA) and industrial and other commercial (Commercial) sectors. It derives revenue predominately from the sale of equipment systems, services, construction design-build, and other various immaterial contracts with customers.